ADOCIA

📍 LYON, France🗓 Founded 2005👥 109 employees💰 Last funded Jun 2013
Biotechnology Research🌐 adocia.com
Website LinkedIn
"Innovative medicine for everyone, everywhere"​ Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia operates in the diabetes and metabolic disease field. The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients. For more information, visit our website: www.adocia.com For careers offers, please click to the following link : http://offres.adocia.com/en
3
Total investors
1
Early stage
1
Mid stage
1
Late stage
2005
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
France
2
Belgium
1
Investor activity2007–2013 · investors recorded per year
200712009120131
Recent (last 2y)Earlier
Frequently asked questions
Who invested in ADOCIA?
ADOCIA has 3 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did ADOCIA last raise funding?
The most recent investment in ADOCIA recorded on gritt.io was in June 2013.
When was ADOCIA founded?
ADOCIA was founded in 2005.
What industry is ADOCIA in?
ADOCIA operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ADOCIA based?
ADOCIA is headquartered in LYON, France.